Healthcare stocks were advancing pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) and iShares Biotechnology ETF (IBB) up 0.8%.
Insmed (INSM) stock was up more than 28% after the company posted a narrower Q2 loss, as revenue increased during the period, and raised its Brinsupri revenue guidance for 2026.